Company Overview and News

 
Metminco announces rights issue take-up of around 72%

2018-04-20 proactiveinvestors.com.au
Mining group Metminco Limited (LON:MNC, ASX:MNC) revealed there had been take-up of around 72% of the previously announced revised rights issue.
Upvote Downvote

 
Metminco announces around 72% of take-up under rights issue

2018-04-20 proactiveinvestors.com.au
Mining group Metminco Limited (LON:MNC, ASX:MNC) revealed there had been take-up of around 72% of the previously announced revised rights issue.
Upvote Downvote

 
Results show Metminco with cash in the bank and in possession of a robust feasibility study for Miraflores

2018-04-03 proactiveinvestors.com.au
Metminco Limited (ASX:MNC)(LON:MNC) booked losses of A$35mln in the year to December 2017, down significantly from the A$124mln booked in the corresponding period a year earlier.
Upvote Downvote

 
Results for the year to December show Metminco with cash in the bank and in possession of a robust feasibility study for Miraflores

2018-04-03 proactiveinvestors.com.au
Metminco Limited (ASX:MNC)(LON:MNC) booked losses of A$35mln in the year to December 2017, down significantly from the A$124mln booked in the corresponding period a year earlier.
Upvote Downvote

 
Metminco launches bigger rights issue amid strategy shift and board changes

2018-03-23 proactiveinvestors.com.au
Metminco Limited (LON:MNC) (ASX:MNC) said it is now seeking to raise A$5.7mln through a revised rights issue as it shifts its strategy and has named a new executive chairman.
Upvote Downvote

 
Metminco announces A$5.1mln rights issue to fund exploration in Colombia

2018-03-05 proactiveinvestors.com.au
Metminco Limited (ASX:MNC)(AIM:MNC) is seeking to raise up to A$5.3m through a A$51.mln rights issue and A$190,000 placement.
Upvote Downvote

 
Metminco cancels March meeting as Redfield requests to redeem notes

2018-02-27 proactiveinvestors.com.au
Metminco Limited (LON:MNC; ASX:MNC) said it has cancelled its extraordinary general meeting at the request of Redfield Asset Management and is in talks about raising capital to boost its cash position.
Upvote Downvote

 
Metminco stakeholder Lanstead Capital sells roughly half of its stake to Lanstead III

2018-02-08 proactiveinvestors.com.au
Lanstead Capital LP, a substantial shareholder in Metminco Ltd (LON:MNC, ASX:MNC), has cut its stake in the gold mine developer.
Upvote Downvote

 
Metminco submits plan of works for Miraflores gold project

2018-01-31 proactiveinvestors.com.au
Ram Venkat, non-executive director at Metminco Ltd (ASX: MNC)(LON:MNC), tells Proactive they've submitted a plan of works to the Colombian Mining Agency for the Miraflores gold project.
Upvote Downvote

 
Metminco submits plan of works for Miraflores

2018-01-29 proactiveinvestors.com.au
Metminco Ltd (ASX: MNC)(LON:MNC) has submitted a plan of works to the Colombian Mining Agency for the Miraflores gold project.
Upvote Downvote

 
Metminco keen to start construction at Miraflores project mid-2018

2017-12-02 proactiveinvestors.com.au
Metminco Ltd (LON:MNC, ASX:MNC) managing director William Howe and non-exec director Ram Venkat update Proactive on the latest at their Miraflores gold project in Colombia.
Upvote Downvote

 
Metminco keen to start to construction at Miraflores project mid-2018

2017-12-01 proactiveinvestors.com.au
Metminco Ltd (LON:MNC, ASX:MNC) managing director William Howe and non-exec director Ram Venkat update Proactive on the latest at their Miraflores gold project in Colombia.
Upvote Downvote

 
Metminco draws attention in London as it emerges from slumber

2017-11-29 proactiveinvestors.com.au
With half of the small-cap mining world here in London for three big conferences this week there has been plenty of chatter about stocks ready to pop.
Upvote Downvote

 
Chairman resignation

2017-08-03 londonstockexchange
Metminco Limited ("Metminco" or the "Company") (ASX: MNC; AIM: MNC) today announces the resignation of Dr Phillip Wing as Chairman effective Thursday, 3 August 2017.
Upvote Downvote

 
Senior Management Change

2017-07-14 londonstockexchange
Metminco Limited ("Metminco" or the "Company") (ASX: MNC; AIM: MNC) announces that Philip Killen will be leaving the Company effective Friday 14 July 2017.
Upvote Downvote

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

23h - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...